XENE SCHEDULE 13G: SEC filing

Polar Capital Holdings Plc and its subsidiary Polar Capital LLP

Filed with the SEC on · accession 0001172661-26-005106

XENE filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Polar Capital Holdings Plc and its subsidiary Polar Capital LLP filed a Schedule 13G disclosing a passive ownership stake of 5,022,084 shares, or 5.19%, in Xenon Pharmaceuticals Inc. as of September 30, 2026.

Key details

Shares beneficially owned$5.0M
Percent of class owned$5
Filer / beneficial ownerPolar Capital Holdings Plc
Filer / beneficial ownerPolar Capital LLP
IssuerXenon Pharmaceuticals Inc.
Chief operating officerNicholas Farren

✦ Ask GOAX AI about this filing — what it means for XENE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for XENE?

Click here

Frequently asked questions

What did XENE file with the SEC on Nov 16, 2026?

XENE filed a SCHEDULE 13G (SEC filing). Polar Capital Holdings Plc and its subsidiary Polar Capital LLP filed a Schedule 13G disclosing a passive ownership stake of 5,022,084 shares, or 5.19%, in Xenon Pharmaceuticals Inc. as of September 30, 2026.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

Other XENE SEC filings

Get alerts when XENE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days